The HPAPI: Highly Potent Drug Manufacturing Summit is back for its 14th year—bigger, better, and free* for the first time for drug developers!

With the global highly potent drug market projected to hit $46.9B by 2030, driven by cutting-edge drug delivery technologies, regulatory advancements, and the push for personalized medicine, the oncology sector continues to lead the charge with small molecules, conjugates, and other targeted therapies.

This year, the summit features a revamped agenda packed with in-depth case studies on cytotoxic compound development, process collaboration, and safe scale-up strategies. Hear from some of our most renowned speakers and network with your forward-thinking peers.

Join 80+ industry leaders across CMC, Tech Ops, Process Chemistry, Drug Substance & Product, EHS, and Industrial Hygiene in Boston to:

• Secure the best CDMO partner
• Optimize process development
• Enhance occupational safety

Don’t miss this opportunity to connect with experts from Pfizer, Bristol Myers Squibb, Johnson & Johnson, Biogen, Teva Pharmaceuticals, Relay Therapeutics, and more!